Animal models of heart failure: a scientific statement from the American Heart Association.
暂无分享,去创建一个
Francis G Spinale | Steven R Houser | Gary S Francis | Mark A Sussman | Kenneth B Margulies | David A Kass | Anne M Murphy | Sumanth D Prabhu | Walter J Koch | Jeffery D Molkentin | Howard A Rockman
[1] S. Morioka,et al. Echocardiographic evidence for early left ventricular hypertrophy in dogs with renal hypertension. , 1982, The American journal of cardiology.
[2] K. Ellenbogen,et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. , 1997, Journal of the American College of Cardiology.
[3] E. Herrold,et al. Myocardial Fibrosis in Chronic Aortic Regurgitation: Molecular and Cellular Responses to Volume Overload , 2002, Circulation.
[4] J. Violin,et al. β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection , 2007 .
[5] O. Hess,et al. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. , 1989, Circulation.
[6] C. Hall. NT-ProBNP: the mechanism behind the marker. , 2005, Journal of cardiac failure.
[7] E. Kranias,et al. From mouse to man: understanding heart failure through genetically altered mouse models. , 2002, Journal of cardiac failure.
[8] Robert C Gorman,et al. Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[9] G. Freeman,et al. beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. , 2000, Circulation.
[10] U. Eriksson,et al. Phosphoinositide 3-Kinase &ggr;–Deficient Mice Are Protected From Isoproterenol-Induced Heart Failure , 2003 .
[11] M. Bohlooly-y,et al. Murine models for the study of congestive heart failure: Implications for understanding molecular mechanisms and for drug discovery. , 2004, Journal of pharmacological and toxicological methods.
[12] T. Sejersen,et al. Desmin mutations in a St. Petersburg cohort of cardiomyopathies. , 2006, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[13] S. Goldstein,et al. Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. , 2006, American journal of physiology. Heart and circulatory physiology.
[14] C. H. Chen,et al. Single-beat estimation of end-systolic pressure-volume relation in humans. A new method with the potential for noninvasive application. , 1996, Circulation.
[15] M. Drazner. The transition from hypertrophy to failure: how certain are we? , 2005, Circulation.
[16] M. Anderson. CaMKII and a failing strategy for growth in heart. , 2009, The Journal of clinical investigation.
[17] D. Kaye,et al. Percutaneous Mitral Annular Reduction Provides Continued Benefit in an Ovine Model of Dilated Cardiomyopathy , 2004, Circulation.
[18] T. Sejersen,et al. Deletion in TNNI3 gene is associated with restrictive cardiomyopathy. , 2009, International journal of cardiology.
[19] R. Bolli,et al. Postinfarct Cytokine Therapy Regenerates Cardiac Tissue and Improves Left Ventricular Function , 2006, Circulation research.
[20] D. Meldrum,et al. Animal models of myocardial and vascular injury. , 2010, The Journal of surgical research.
[21] Rishard Salie,et al. Deferasirox Reduces Iron Overload in a Murine Model of Juvenile Hemochromatosis , 2009, Experimental biology and medicine.
[22] W. Linz,et al. A model of chronic heart failure in spontaneous hypertensive rats (SHR) , 2004, Laboratory animals.
[23] E. Arbustini,et al. Pure restrictive cardiomyopathy associated with cardiac troponin I gene mutation: mismatch between the lack of hypertrophy and the presence of disarray , 2007, Heart.
[24] M. Drazner,et al. Left Ventricular Hypertrophy Is More Prevalent in Blacks Than Whites in the General Population: The Dallas Heart Study , 2005, Hypertension.
[25] K. Brunt,et al. Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. , 2007, American journal of physiology. Heart and circulatory physiology.
[26] N. Ageyama,et al. Transthyretin Amyloidosis and Two Other Aging-Related Amyloidoses in an Aged Vervet Monkey , 2008, Veterinary pathology.
[27] T. Moore,et al. Collagenous abnormalities in the heart of the tight-skin mouse. , 1987, Journal of molecular and cellular cardiology.
[28] H. Michelena,et al. Contribution of ventricular diastolic dysfunction to pulmonary hypertension complicating chronic systolic heart failure. , 2011, JACC. Cardiovascular imaging.
[29] J. Pilla,et al. Cardiac Support Device Modifies Left Ventricular Geometry and Myocardial Structure After Myocardial Infarction , 2005, Circulation.
[30] J. Potter,et al. Cardiac Troponin Mutations and Restrictive Cardiomyopathy , 2010, Journal of biomedicine & biotechnology.
[31] M. Pfeffer,et al. Myocardial Infarct Size and Ventricular Function in Rats , 1979, Circulation research.
[32] V. Maupoil,et al. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[33] P. Grayburn,et al. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. , 1990, Circulation.
[34] T. Kohout,et al. Augmentation of Cardiac Contractility Mediated by the Human &bgr;3-Adrenergic Receptor Overexpressed in the Hearts of Transgenic Mice , 2001, Circulation.
[35] M. Chandler,et al. The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure. , 2010, American journal of physiology. Heart and circulatory physiology.
[36] M. Tarr,et al. Tissue distribution of amyloid deposits in Abyssinian cats with familial amyloidosis. , 1986, Journal of comparative pathology.
[37] E. Monnet,et al. A canine model of heart failure by intracoronary adriamycin injection: hemodynamic and energetic results. , 1999, Journal of cardiac failure.
[38] S. Jimenez,et al. Increased collagen synthesis and increased content of type VI collagen in myocardium of tight skin mice. , 1993, Cardiovascular research.
[39] M. Gheorghiade,et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. , 1991, The American journal of physiology.
[40] Jeffrey Robbins,et al. A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.
[41] D. Levy,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.
[42] G. Wang,et al. Divergent Tumor Necrosis Factor Receptor-Related Remodeling Responses in Heart Failure: Role of Nuclear Factor-&kgr;B and Inflammatory Activation , 2009, Circulation.
[43] S. Hunyor,et al. Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses. , 2004, American journal of physiology. Heart and circulatory physiology.
[44] Hiroshi Sato,et al. Intracoronary Administration of Cardiac Progenitor Cells Alleviates Left Ventricular Dysfunction in Rats With a 30-Day-Old Infarction , 2010, Circulation.
[45] G. Giridharan,et al. Bovine Model of Doxorubicin-Induced Cardiomyopathy , 2010, Journal of biomedicine & biotechnology.
[46] D. Lehotay,et al. Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload. , 1999, Cardiovascular research.
[47] Francis G Spinale,et al. Large animal models of congestive heart failure: A critical step in translating basic observations into clinical applications , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[48] T. Elton,et al. Cardiomyopathy: an overview. , 2009, American family physician.
[49] N. Doll,et al. Regression of Left Ventricular Hypertrophy After Surgical Therapy for Aortic Stenosis Is Associated With Changes in Extracellular Matrix Gene Expression , 2001, Circulation.
[50] M. Entman,et al. Myocardial ischemia and reperfusion: a murine model. , 1995, The American journal of physiology.
[51] J. Potter,et al. Functional effects of a restrictive-cardiomyopathy-linked cardiac troponin I mutation (R145W) in transgenic mice. , 2009, Journal of molecular biology.
[52] M. Zile,et al. Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload. , 1993, The Journal of thoracic and cardiovascular surgery.
[53] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[54] G. Aurigemma,et al. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. , 1995, Journal of the American College of Cardiology.
[55] H. Traxler,et al. Selective Downregulation of VEGF-A165, VEGF-R1, and Decreased Capillary Density in Patients With Dilative but Not Ischemic Cardiomyopathy , 2000, Circulation research.
[56] S. Hunyor,et al. STABLE OVINE CONGESTIVE HEART FAILURE (CHF) MODEL SUITABLE FOR LVAD ASSESSMENT , 1997 .
[57] M. Benson,et al. Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides , 2006, Muscle & nerve.
[58] M. Zile,et al. The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. , 1993, Journal of molecular and cellular cardiology.
[59] Gerdes Am,et al. Structural remodeling of cardiac myocytes in rats with arteriovenous fistulas. , 1988 .
[60] Carissa G. Fonseca,et al. Cardiomyopathy is associated with structural remodelling of heart valve extracellular matrix. , 2009, European heart journal.
[61] R. Falk,et al. Amyloid heart disease. , 2010, Progress in cardiovascular diseases.
[62] W. Little,et al. Contribution of systolic and diastolic abnormalities to heart failure with a normal and a reduced ejection fraction. , 2007, Progress in cardiovascular diseases.
[63] B. Jugdutt,et al. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction. , 2004, Journal of cardiac failure.
[64] J. S. Janicki,et al. Effects of Matrix Metalloproteinase Inhibition on Ventricular Remodeling Due to Volume Overload , 2002, Circulation.
[65] A. Caspi,et al. Familial cardiomyopathy with variable hypertrophic and restrictive features and common HLA haplotype. , 1992, Israel journal of medical sciences.
[66] E. Everett,et al. The tight skin mouse: an animal model of systemic sclerosis. , 2004, Clinical and experimental rheumatology.
[67] K. Mani,et al. Death begets failure in the heart. , 2005, The Journal of clinical investigation.
[68] S. Oparil,et al. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. , 1999, Journal of molecular and cellular cardiology.
[69] R. Lefkowitz,et al. Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[70] P. Armstrong,et al. Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. , 1989, Journal of the American College of Cardiology.
[71] K. Chien,et al. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. , 2007, Journal of the American College of Cardiology.
[72] Dimitrios Georgakopoulos,et al. The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation , 1999, Nature Medicine.
[73] G. Hasenfuss,et al. Biventricular Pacing Improves the Blunted Force–Frequency Relation Present During Univentricular Pacing in Patients With Heart Failure and Conduction Delay , 2006, Circulation.
[74] Guy Salama,et al. Calmodulin kinase II inhibition protects against structural heart disease , 2005, Nature Medicine.
[75] Roger R Markwald,et al. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. , 2010, The Journal of clinical investigation.
[76] Yu-yu Yao,et al. Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction , 2011, International journal of nanomedicine.
[77] S. Prabhu. Post-infarction ventricular remodeling: an array of molecular events. , 2005, Journal of molecular and cellular cardiology.
[78] B. Pieske,et al. Reduced Stretch-Induced Force Response in Failing Human Myocardium Caused by Impaired Na+-Contraction Coupling , 2009, Circulation. Heart failure.
[79] W. Koch,et al. Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress , 2002, Circulation.
[80] J. Daurès,et al. An Ovine Model of Chronic Heart Failure: Echocardiographic and Tissue Doppler Imaging Characterization , 2006, Journal of cardiac surgery.
[81] R. Bolli,et al. Cardioprotective and Antiapoptotic Effects of Heme Oxygenase-1 in the Failing Heart , 2010, Circulation.
[82] J. Grande,et al. Load Versus Humoral Activation in the Genesis of Early Hypertensive Heart Disease , 2001, Circulation.
[83] O. Hess,et al. Diastolic dysfunction in aortic stenosis. , 1993, Circulation.
[84] M. Pfeffer,et al. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. , 1994, Circulation research.
[85] J. Bauer,et al. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. , 2000, The Journal of pharmacology and experimental therapeutics.
[86] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[87] J. Robert. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors , 2007, Cardiovascular Toxicology.
[88] X. Huang,et al. A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice. , 2006, Archives of biochemistry and biophysics.
[89] L. Dell’Italia,et al. Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats. , 2003, American journal of physiology. Heart and circulatory physiology.
[90] Cinzia Perrino,et al. Network integration of the adrenergic system in cardiac hypertrophy. , 2004, Cardiovascular research.
[91] M. D. de Santi,et al. Cardiac collagen changes during the development of right ventricular hypertrophy in tight-skin mice with emphysema. , 1994, Experimental and molecular pathology.
[92] G. Newton,et al. Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure. , 2004, American journal of physiology. Heart and circulatory physiology.
[93] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[94] Rebekah Drezek,et al. In vivo biodistribution of nanoparticles. , 2011, Nanomedicine.
[95] O. Hess,et al. Time course of regression of left ventricular hypertrophy after aortic valve replacement. , 1988, Circulation.
[96] Douglas L Mann,et al. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.
[97] R. Kerber,et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. , 2000, Circulation.
[98] W. Lederer,et al. Cellular and functional defects in a mouse model of heart failure. , 2000, American journal of physiology. Heart and circulatory physiology.
[99] Hiroshi Sato,et al. Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading. , 1998, Circulation research.
[100] R. Bolli,et al. Chronic AMD3100 antagonism of SDF-1alpha-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction. , 2010, Journal of molecular and cellular cardiology.
[101] C A Beltrami,et al. Apoptosis in the failing human heart. , 1997, The New England journal of medicine.
[102] J. Thomas,et al. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. , 1996, Journal of the American College of Cardiology.
[103] R. Moats,et al. Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil. , 2006, Translational research : the journal of laboratory and clinical medicine.
[104] D. Chatel,et al. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. , 1998, Circulation.
[105] T. Tuschl,et al. MicroRNA-24 Regulates Vascularity After Myocardial Infarction , 2011, Circulation.
[106] A. Curcio,et al. Competitive displacement of phosphoinositide 3-kinase from beta-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling. , 2006, American journal of physiology. Heart and circulatory physiology.
[107] G. Dorn,et al. Decompensation of Pressure-Overload Hypertrophy in Gαq-Overexpressing Mice , 1998 .
[108] P. Elliott,et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. , 2003, The Journal of clinical investigation.
[109] Donald M Bers,et al. Cellular Basis of Abnormal Calcium Transients of Failing Human Ventricular Myocytes , 2003, Circulation research.
[110] L. Dell’Italia,et al. Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog. , 2002, Journal of the American College of Cardiology.
[111] G. Monreal,et al. Selective microembolization of the circumflex coronary artery in an ovine model: Dilated, ischemic cardiomyopathy and left ventricular dysfunction. , 2004, Journal of cardiac failure.
[112] M. Feldman,et al. Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy. , 1988, The Journal of clinical investigation.
[113] C A Beltrami,et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. , 1994, Circulation.
[114] L. Tavazzi,et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects , 2006, European journal of heart failure.
[115] M. Beer,et al. Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis , 2009, Circulation.
[116] Douglas P. Zipes,et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition , 2011 .
[117] Joshua M Hare,et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[118] G. Gong,et al. High-Energy Phosphate Metabolism and Creatine Kinase in Failing Hearts: A New Porcine Model , 2001, Circulation.
[119] E. T. Adams,et al. Morphologic Investigations of the Guinea Pig Model of Iron Overload , 1993, Toxicologic pathology.
[120] J. Port,et al. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. , 2001, Journal of molecular and cellular cardiology.
[121] J. Gorman,et al. Infarct size and location determine development of mitral regurgitation in the sheep model. , 1998, The Journal of thoracic and cardiovascular surgery.
[122] M. Redfield,et al. Ventricular Structure and Function in Aged Dogs With Renal Hypertension: A Model of Experimental Diastolic Heart Failure , 2005, Circulation.
[123] Yuko Ito,et al. Mechanism of Inflammation in Murine Eosinophilic Myocarditis Produced by Adoptive Transfer with Ovalbumin Challenge , 2006, International Archives of Allergy and Immunology.
[124] S. Houser,et al. Abnormalities of calcium cycling in the hypertrophied and failing heart. , 2000, Journal of molecular and cellular cardiology.
[125] R. Lefkowitz,et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.
[126] Michael D. Schneider,et al. Sizing up the heart: development redux in disease. , 2003, Genes & development.
[127] Paul Dagum,et al. Tachycardia-induced cardiomyopathy in the ovine heart: mitral annular dynamic three-dimensional geometry. , 2003, The Journal of thoracic and cardiovascular surgery.
[128] R. Karch,et al. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[129] A. Kaminska,et al. Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation. , 2007, International journal of cardiology.
[130] Susan Cheng,et al. Echocardiographic Speckle-Tracking Based Strain Imaging for Rapid Cardiovascular Phenotyping in Mice , 2011, Circulation research.
[131] G. Aurigemma,et al. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. , 1995, Circulation.
[132] Jian-Ping Jin,et al. Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI. , 2008, American journal of physiology. Heart and circulatory physiology.
[133] F. Recchia,et al. Coronary Microvascular Endothelial Stunning After Acute Pressure Overload in the Conscious Dog Is Caused by Oxidant Processes: The Role of Angiotensin II Type 1 Receptor and NAD(P)H Oxidase , 2003, Circulation.
[134] M. Bristow,et al. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. , 1996, Circulation.
[135] D. Kass,et al. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. , 2002, Journal of the American College of Cardiology.
[136] Hyung-Suk Kim,et al. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. , 2006, The Journal of clinical investigation.
[137] M. Redfield,et al. Hemodynamic and Humoral Effects of Vasopeptidase Inhibition in Canine Hypertension , 2002, Hypertension.
[138] J. Ross,et al. Factors influencing indices of left ventricle contractility in the conscious dog. , 1974, Cardiovascular research.
[139] M. Mongillo,et al. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. , 2010, The Journal of clinical investigation.
[140] G. Newton,et al. Unsaturated aldehydes including 4-OH-nonenal are elevated in patients with congestive heart failure. , 2000, Journal of cardiac failure.
[141] D. Bogen,et al. Large animal model of ischemic mitral regurgitation. , 1994, The Annals of thoracic surgery.
[142] T. LeJemtel,et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. , 1996, Journal of the American College of Cardiology.
[143] R. Erbel,et al. Coronary microembolization: from bedside to bench and back to bedside. , 2009, Circulation.
[144] M. Marcus,et al. The heart in hypertension. , 1992, The New England journal of medicine.
[145] J. Feijen,et al. Morphometric study of myocardial changes during doxorubicin-induced cardiomyopathy in mice. , 1988, European journal of cancer & clinical oncology.
[146] D. Renlund,et al. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. , 1995, The American journal of cardiology.
[147] T. Ahluwalia,et al. Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy , 2009, Molecular and Cellular Biochemistry.
[148] M. Pfeffer,et al. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[149] S. Houser,et al. Repair of the Injured Adult Heart Involves New Myocytes Potentially Derived From Resident Cardiac Stem Cells , 2011, Circulation research.
[150] J. Ghiso,et al. Amyloid and Nonfibrillar Deposits in Mice Transgenic for Wild-Type Human Transthyretin: A Possible Model for Senile Systemic Amyloidosis , 2001, Laboratory Investigation.
[151] M. Boerma,et al. Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. , 2008, International journal of radiation oncology, biology, physics.
[152] R. Lefkowitz,et al. Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[153] William C. Little,et al. The cardiac cycle and the physiologic basis of left ventricular contraction, ejection, relaxation, and filling. , 2008, Heart failure clinics.
[154] R. Winslow,et al. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. , 1999, Circulation research.
[155] N. Sebire,et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes , 2008, Heart.
[156] A. Lochner,et al. Effect of captopril on changes in rats' hearts induced by long-term irradiation. , 1993, Radiation research.
[157] G. Virdi,et al. Clinical and molecular studies of a large family with desmin‐associated restrictive cardiomyopathy , 2001, Clinical genetics.
[158] G. Beller,et al. Contractile Function, Myosin ATPase Activity and Isozymes in the Hypertrophied Pig Left Ventricle after a Chronic Progressive Pressure Overload , 1983, Circulation research.
[159] P. Gillette,et al. Right and left ventricular geometry and myocyte contractile processes with dilated cardiomyopathy: myocyte growth and β-adrenergic responsiveness , 1996 .
[160] F. Spinale,et al. Large animal models of heart failure: a critical link in the translation of basic science to clinical practice. , 2009, Circulation. Heart failure.
[161] H. Goebel,et al. The enlarging spectrum of desminopathies: new morphological findings, eastward geographic spread, novel exon 3 desmin mutation , 2005, Acta Neuropathologica.
[162] R. Lefkowitz,et al. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.
[163] H. Uno,et al. Mechanical Dyssynchrony After Myocardial Infarction in Patients With Left Ventricular Dysfunction, Heart Failure, or Both , 2010, Circulation.
[164] M. Zile,et al. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. , 1991, The American journal of physiology.
[165] A. Werdich,et al. The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion , 2011, Development.
[166] T. Matsui,et al. Immunohistochemical distribution of amyloid deposits in 25 cows diagnosed with systemic AA amyloidosis. , 2006, The Journal of veterinary medical science.
[167] R. Stevens,et al. HFE Mutation and Dietary Iron Content Interact to Increase Ischemia/Reperfusion Injury of the Heart in Mice , 2003, Circulation research.
[168] L. Tilley,et al. Animal models of primary myocardial diseases. , 1980, The Yale journal of biology and medicine.
[169] F. Lázaro,et al. Iron speciation study in Hfe knockout mice tissues: magnetic and ultrastructural characterisation. , 2009, Biochimica et biophysica acta.
[170] D. Kass,et al. Assessment of ventricular function in dilated cardiomyopathies. , 1995, Current opinion in cardiology.
[171] J. Ross,et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[172] K. Nagata,et al. Drastic Ca2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy. , 2005, Biochemical and biophysical research communications.
[173] G. Pinkus,et al. A mouse model of juvenile hemochromatosis. , 2005, The Journal of clinical investigation.
[174] H. Suga,et al. Heart size-independent analysis of myocardial function in murine pressure overload hypertrophy. , 2002, American journal of physiology. Heart and circulatory physiology.
[175] R. Patten,et al. Small animal models of heart failure: development of novel therapies, past and present. , 2009, Circulation. Heart failure.
[176] D. Yellon,et al. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. , 1987, Cardiovascular research.
[177] D. Mozaffarian,et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[178] Barry J Maron,et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.
[179] M. Pfeffer,et al. Left Ventricular Diastolic Pressure‐Volume Relations in Rats with Healed Myocardial Infarction: Effects on Systolic Function , 1981, Circulation research.
[180] E. Sonnenblick,et al. The cellular basis of dilated cardiomyopathy in humans. , 1995, Journal of molecular and cellular cardiology.
[181] Douglas L Mann,et al. Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.
[182] W. Gaasch,et al. Left Ventricular Midwall Mechanics in Systemic Arterial Hypertension Myocardial Function is Depressed in Pressure‐Overload Hypertrophy , 1991, Circulation.
[183] N. Smedira,et al. Mechanical Unloading Restores &bgr;-Adrenergic Responsiveness and Reverses Receptor Downregulation in the Failing Human Heart , 2001, Circulation.
[184] D. Mann,et al. Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .
[185] R. Lafyatis,et al. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen. , 2004, Arthritis and rheumatism.
[186] D. Kass,et al. In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry. , 1998, American journal of physiology. Heart and circulatory physiology.
[187] Nancy M Albert,et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. , 2010, Journal of cardiac failure.
[188] A. Day,et al. Experimental aortocaval fistulae in rats , 1981, Journal of microsurgery.
[189] S. Gilbertson,et al. Primary myocardial disease in the cat. A model for human cardiomyopathy. , 1977, The American journal of pathology.
[190] J. Omens,et al. Passive ventricular mechanics in tight-skin mice. , 1994, The American journal of physiology.
[191] Pál Pacher,et al. Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats , 2008, Nature Protocols.
[192] M. Boerma,et al. Preclinical Research into Basic Mechanisms of Radiation-Induced Heart Disease , 2010, Cardiology research and practice.
[193] Jian Du,et al. Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy. , 2004, Acta pharmacologica Sinica.
[194] G. Hasenfuss,et al. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. , 1995, Circulation.
[195] S. Hunyor,et al. A Stable Ovine Congestive Heart Failure Model A Suitable Substrate for Left Ventricular Assist Device Assessment , 1997, ASAIO journal.
[196] D. Duncker,et al. Alterations in Myofilament Function Contribute to Left Ventricular Dysfunction in Pigs Early After Myocardial Infarction , 2004, Circulation research.
[197] J. Chachques,et al. Animal models of heart failure: what is new? , 2005, The Annals of thoracic surgery.
[198] R. Kernoff,et al. Acute and Chronic Cardiovascular Effects of Doxorubicin in the Dog: The Cardiovascular Pharmacology of Drug‐Induced Histamine Release , 1980, Journal of cardiovascular pharmacology.
[199] J. Schaper,et al. Myocytes Die by Multiple Mechanisms in Failing Human Hearts , 2003, Circulation research.
[200] P. Carmeliet,et al. Increased Cardiac Expression of Tissue Inhibitor of Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-2 Is Related to Cardiac Fibrosis and Dysfunction in the Chronic Pressure-Overloaded Human Heart , 2005, Circulation.
[201] J. Laragh,et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. , 1992, Journal of the American College of Cardiology.
[202] J. Bristow,et al. A quantitative study of the anatomy and distribution of coronary arteries in swine in comparison with other animals and man. , 1986, Cardiovascular research.
[203] N. Bursac,et al. A Method to Measure Myocardial Calcium Handling in Adult Drosophila , 2011, Circulation research.
[204] John M. Miller,et al. Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. , 2008, Heart rhythm.
[205] W. Linke,et al. Mineralocorticoid Signaling in Transition to Heart Failure With Normal Ejection Fraction , 2008, Hypertension.
[206] R. Weiss,et al. Targeted Inhibition of Calcineurin in Pressure-overload Cardiac Hypertrophy , 2002, The Journal of Biological Chemistry.
[207] G. Dorn. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. , 2008, Cardiovascular research.
[208] Donald M Bers,et al. Altered cardiac myocyte Ca regulation in heart failure. , 2006, Physiology.
[209] Paul Dagum,et al. Mitral Leaflet Remodeling in Dilated Cardiomyopathy , 2006, Circulation.
[210] B. Carabello,et al. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. , 1994, The Journal of clinical investigation.
[211] P. Ping,et al. Beta-adrenergic receptor blockade modulates Bcl-X(S) expression and reduces apoptosis in failing myocardium. , 2003, Journal of molecular and cellular cardiology.
[212] Cory Swingen,et al. Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling , 2007, Circulation.
[213] Y. Toyoda,et al. A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration. , 1998, The Journal of thoracic and cardiovascular surgery.
[214] W. Little,et al. Clinical evaluation of left ventricular diastolic performance. , 1990, Progress in cardiovascular diseases.
[215] N. Sharpe,et al. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.
[216] Load sensitivity of left ventricular relaxation in normal and failing hearts: evidence of a nonlinear biphasic response. , 1999, Cardiovascular research.
[217] G. Freeman,et al. Effect of tachycardia heart failure on the restitution of left ventricular function in closed-chest dogs. , 1995, Circulation.
[218] E. Marbán,et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. , 2011, Journal of the American College of Cardiology.
[219] B. Swynghedauw,et al. Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.
[220] R. Zimmerman,et al. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. , 1988, Circulation research.
[221] E. Herrold,et al. Differential Expression of Matrix Metalloproteinases and Tissue Inhibitors and Extracellular Matrix Remodeling in Aortic Regurgitant Hearts , 2009, Cardiology.